Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2023-08-09 00:00:00 ET · period of report 2023-08-07 · accession 0001048477-23-000031 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-08-09 | 2023-08-07+ | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | S - Sale | $88.21 | -10.0K | 422.7K | -2% | -$882.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-07 | S | D | 4,000 | $88.10 | 428,732 | D | — | — | |
| 2 | Common | Common Stock | 2023-08-08 | S | D | 6,000 | $88.29 | 422,732 | D | — | — |